Shatavari (Asparagus racemosus) is an ayurvedic herb traditionally used for women's reproductive health, sold for menopause symptoms, breast milk and libido. The evidence in people is a few small, short placebo-controlled trials.
Also known as: Asparagus racemosus, satavar.
A perimenopause trial used 300 mg of root extract once a day for 8 weeks (Mahajan 2025). These are study protocols, not a recommendation.
It is sold in the US as a dietary supplement. Under the 1994 dietary supplement law (DSHEA), FDA does not approve dietary supplements before they are marketed, and the maker, not FDA, is responsible for safety and labeling.
What studies show: in an 8-week trial in 80 women with perimenopausal symptoms, shatavari root extract improved menopause rating scores, hot flashes and stress compared with placebo, and estradiol levels rose (Mahajan 2025). In a multicenter Indian trial of 70 women with menopausal symptoms, a shatavari formulation reduced hot flashes, night sweats, sleep problems and anxiety more than placebo (Gudise 2024). Both trials were small and short, and both sets of authors call for larger, longer studies.
Safety: neither trial reported significant side effects or changes in liver or kidney function (Mahajan 2025, Gudise 2024). The sources here do not describe drug interactions.
We could not find a single published half-life or time to peak for shatavari that applies to a supplement dose, so we do not list one. Plant extracts are mixtures of many compounds, so no single figure would describe them.
How Dose Track handles peptides · Reconstitution calculator · Half-life calculator